No Data
Express News | Citizens Capital Markets Reiterates Market Outperform on Integra Lifesciences, Maintains $35 Price Target
Integra Lifesciences Analyst Ratings
Morgan Stanley Maintains Integra Lifesciences(IART.US) With Sell Rating, Maintains Target Price $20
Truist Financial Maintains Integra Lifesciences(IART.US) With Hold Rating
A Quick Look at Today's Ratings for Integra Lifesciences(IART.US), With a Forecast Between $20 to $35
Integra Lifesciences Faces Supply Chain Challenges and Conservative Outlook, Leading to Sell Rating
Money Mover OP : $Medtronic (MDT.US)$ $Intuitive Surgical (ISRG.US)$